ORAMED PHARMACEUTICALS INC. Stock Agreements
8 Contracts & Agreements
- Second Amendment to Stock Purchase Agreement dated as of August 21, 2023, between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc (Filed With SEC on August 22, 2023)
- First Amendment to Stock Purchase Agreement dated August 9, 2023, by and between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc (Filed With SEC on August 10, 2023)
- Stock Purchase Agreement dated as of August 7, 2023, between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc (Filed With SEC on August 9, 2023)
- Oravax Stock Option Agreement (Filed With SEC on March 6, 2023)
- Form of Restricted Stock Unit Notice and Restricted Stock Unit Agreement (Filed With SEC on March 6, 2023)
- Form of Notice of Stock Option Award and Stock Option Award Agreement (Filed With SEC on November 27, 2019)
- Form of Restricted Stock Unit Notice and Restricted Stock Unit Agreement between the Company and the CSO or CEO (Filed With SEC on November 29, 2017)
- ORAMED PHARMACEUTICALS INC. Common Stock (par value $0.012 per share) (Filed With SEC on April 3, 2015)
